NASDAQ: KPTI Long Term Investor Notice: Investigation of Potential Wrongdoing at Karyopharm Therapeutics Inc.
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Karyopharm Therapeutics Inc..
View full press release